Influenza vaccine antibody responses in lung transplant recipients

Progress in Transplantation

Volumn 14, Issue 4, 2004, Pages 346-351

  Hayney, Mary S ^a   Welter, Deborah L ^a   Francois, Mary ^a   Reynolds, Marie ^a   Love, Robert B ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; INFLUENZA VACCINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT;

ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; FEMALE; HEMAGGLUTINATION INHIBITION TEST; HUMAN; IMMUNE DEFICIENCY; INFLUENZA; INFLUENZA VACCINATION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; UNIVERSITY HOSPITAL; ADULT; AGED; ANTIBODY PRODUCTION; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; IMMUNOLOGY; MIDDLE AGED; NONPARAMETRIC TEST;

ADULT; AGED; ANTIBODY FORMATION; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLUENZA VACCINES; INFLUENZA, HUMAN; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC;

EID: 13844306522     PISSN: 15269248     EISSN: None     Source Type: Journal    
DOI: 10.7182/prtr.14.4.g5417348370w2n83     Document Type: Article

References (28)

1. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2003;52:1-34. No. RR-8.
2. Blumberg EA, Albano C, Pruett T, et al. The immunogenicity of influenza virus vaccine in solid organ transplant recipients. Clin Infect Dis. 1996;22:295-302.
3. Ljungman P, Andersson J, Aschan J, et al. Influenza A in immunocompromised subjects. Clin Infect Dis. 1993;17: 244-247.
4. Mauch TJ, Bratton S, Myers T, Krane E, Gentry SR, Kashtan CE. Influenza B virus infection in pediatric solid organ transplant recipients. Pediatrics. 1994;94:225-229.
5. Wendt CH. Community respiratory viruses: organ transplant recipients. Am J Med. March 1997;102:31-36; discussion 42-43.
6. Beyer WE, Diepersloot RJ, Masurel N, Simoons ML, Weimar W. Double failure of influenza vaccination in a heart transplant subject. Transplantation. 1987;43:319.
7. Frost AE. Role of infections, pathogenesis, and management in lung transplantation. Transplant Proc. 1999;31:175-177.
8. Stark K, Gunther M, Schonfeld C, Tullius SG, Bienzle U. Immunisations in solid-organ transplant recipients. Lancet. 2002;359:957-965.
9. Levine M, Beattie BL, McLean DM, Corman D. Characterization of the immune response to trivalent influenza vaccine in elderly men. J Am Geriatr Soc. 1987;35:609-615.
10. Phair J, Kauffman CA, Bjornson A, Adams L, Linnemann C Jr. Failure to respond to influenza vaccine in the aged: correlation with B-cell number and function. J Lab Clin Med. 1978;92:822-828.
11. Mazzone PJ, Mossad SB, Mawhorter SD, Mehta AC, Schilz RJ, Maurer JR. The humoral immune response to influenza vaccination in lung transplant subjects. Eur Respir J. 2001; 18:971-976.
12. Centers for Disease Control. Advanced Laboratory Techniques for Influenza Diagnosis. Atlanta, Ga: Public Health Service; 1975.
13. Keitel WA, Cate TR, Couch RB. Efficacy of sequential annual vaccination with inactivated influenza virus vaccine. Am J Epidemioi 1988;127:353-364.
14. Powers DC, Belshe RB. Effect of age on cytotoxic T lymphocyte membory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine. J Infect Dis. 1993;167:584-592.
15. Powers DC, Hanscome PJ, Pietrobon PJ. In previously immunized elderly adults inactivated influenza A (H1N1) virus vaccines induce poor antibody responses that are not enhanced by liposome adjuvant. Vaccine. 1995;13:1330-1335.
16. Dorrell L, Hassan I, Marshall S, Chakraverty P, Ong E. Clinical and serological responses to an inactivated influenza vaccine in adults with HIV infection, diabetes, obstructive airways disease, elderly adults and healthy volunteers. Int J STD AIDS. 1997;8:776-779.
17. Arcasoy SM, Kotloff RM. Lung transplantation. N Engl J Med. 1999;340:1081-1091.
18. Youssef S, Stuve O, Patarroyo JC, et al. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature. November 2002;420:78-84.
19. Johnson BA, Iacono AT, Zeevi A, McCurry KR, Duncan SR. Statin use is associated with improved function and survival of lung allografts. Am J Resp Crit Care Med. 2003;167:1271-1278.
20. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 1998;47:1-35. No. RR-06.
21. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 1999;48:1-29. No. RR-04.
22. Hayney MS, Welter DL, Reynolds AM, Francois M, Love RB. High dose hepatitis B vaccine in subjects waiting for lung transplantation. Pharmacotherapy. 2003;23:555-560.
23. Rose ML, Smith J, Dureau G, Keogh A, Kobashigowa J. Mycophenolate mofetil decreases antibody production after cardiac transplantation. J Heart Lung Transplant. 2002; 21:282-285.
24. Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons: a meta-analysis and review of the literature. Ann Intern Med. 1995;123:518-527.
25. Demicheli V, Jefferson T, Rivetti D, Deeks J. Prevention and early treatment of influenza in healthy adults. Vaccine. 2000;18:957-1030.
26. Dowdle WR, Coleman MT, Mostow SR, Kaye HS, Schoenbaum SC. Inactivated influenza vaccines. 2. Laboratory indices of protection. Postgrad Med J. 1973;49:159-163.
27. Bernstein ED, Gardner EM, Abrutyn E, Gross P, Murasko DM. Cytokine production after influenza vaccination in a healthy elderly population. Vaccine. 1998;16:1722-1731.
28. McElhaney JE, Herre JM, Lawson ML, Cole SK, Burke BL, Hooton JW. Effect of congestive heart failure on humoral and ex vivo cellular immune responses to influenza vaccination in older adults. Vaccine. 2004;22:682-689.